Study Code: GWCA0962; EudraCT Number: 2009-016065-29; A double blind, randomized, placebo-controlled, parallel group study of Sativex oromucosal spray (Sativex; Nabiximols) as adjunctive therapy in relieving uncontrolled persistent chronic pain in pati

  • Markowitz, Avi, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date4/24/124/23/15

    Funding

    • GW Pharmaceuticals: $11,839.00